in patients with type 2 diabetes treated with metformin  and a sulfonylurea. Diabetes Care. 2005;28:1083-1091.  6. Zinman B, Hoogwerf BJ, Duran Garda S, et al. The effect  of adding exenatide to a thiazolidinedione in subopti-  mally controlled type 2 diabetes: A randomized trial [pub-  lished correction appears in Ann lntem Med. 2007;146:896].  Ann Intern Med. 2007;146:477-485.  7. Heine RJ, Van Gaal LF, Johns D, et al, for the GWAA Study  Group. Exenatide versus insulin glargine in patients with  suboptimally controlled type 2 diabetes: A randomized  trial. Ann Intern Med. 2005;143:559-569.  8. Nauck MA, Duran S, Kim D, et al. A comparison of twice-  daily exenatide and biphasic insulin aspart in patients  with type 2 diabetes who were suboptimally controlled  with sulfonylurea and metformin: A non-inferiority study.  Diabetologia. 2007;50: 259-267.  9. Barnett AH, BurgerJ, Johns D, et al. Tolerability and effi-  cacy of exenatide and titrated insulin glargine in adult